What is Ipca Laboratories Price-to-Operating-Cash-Flow?
As of today (2025-06-04), Ipca Laboratories's share price is ₹1400.15.
Ipca Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00. Hence, Ipca Laboratories's Price-to-Operating-Cash-Flow Ratio for today is .
The historical rank and industry rank for Ipca Laboratories's Price-to-Operating-Cash-Flow or its related term are showing as below:
BOM:524494'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 0 Med: 0 Max: 22.61
Current: 22.61
During the past 13 years, Ipca Laboratories's highest Price-to-Operating-Cash-Flow Ratio was 22.61. The lowest was 0.00. And the median was 0.00.
Ipca Laboratories's Cash Flow from Operations per share for the
three
months ended in Mar. 2025 was ₹0.00.
Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 was ₹0.00.
During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Ipca Laboratories was 41.20% per year.
During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 23.10% per year.
During the past 5 years, the average Operating Cash Flow per Share Growth Rate was 15.90% per year.
During the past 10 years, the average Operating Cash Flow per Share Growth Rate was 13.30% per year.
During the past 13 years, Ipca Laboratories's highest 3-Year average Operating Cash Flow per Share Growth Rate was 47.10% per year. The lowest was -18.60% per year. And the median was 20.75% per year.
Ipca Laboratories Price-to-Operating-Cash-Flow Historical Data
The historical data trend for Ipca Laboratories's Price-to-Operating-Cash-Flow can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ipca Laboratories Price-to-Operating-Cash-Flow Chart
|
Ipca Laboratories Annual Data
|
|
Trend |
Mar16 |
Mar17 |
Mar18 |
Mar19 |
Mar20 |
Mar21 |
Mar22 |
Mar23 |
Mar24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
|
Get a 7-Day Free Trial
|
|
|
22.10 |
31.45 |
25.51 |
27.79 |
23.85 |
|
Ipca Laboratories Quarterly Data
|
|
Jun20 |
Sep20 |
Dec20 |
Mar21 |
Jun21 |
Sep21 |
Dec21 |
Mar22 |
Jun22 |
Sep22 |
Dec22 |
Mar23 |
Jun23 |
Sep23 |
Dec23 |
Mar24 |
Jun24 |
Sep24 |
Dec24 |
Mar25 |
| Price-to-Operating-Cash-Flow |
Get a 7-Day Free Trial
|
|
|
|
|
|
|
|
|
|
|
|
|
27.79 |
- |
- |
- |
23.85 |
Competitive Comparison of Ipca Laboratories's Price-to-Operating-Cash-Flow
For the Drug Manufacturers - Specialty & Generic subindustry, Ipca Laboratories's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ipca Laboratories's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Ipca Laboratories's Price-to-Operating-Cash-Flow distribution charts can be found below:
* The bar in red indicates where Ipca Laboratories's Price-to-Operating-Cash-Flow falls into.
Ipca Laboratories Price-to-Operating-Cash-Flow Calculation
Ipca Laboratories's Price-to-Operating-Cash-Flow ratio for today is calculated as
| Price-to-Operating-Cash-Flow Ratio | = | Share Price | / | Cash Flow from Operations per share (TTM) |
| = | 1400.15 | / | 0 |
| = | |
Ipca Laboratories's Share Price of today is ₹1400.15.
Ipca Laboratories's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹0.00.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).
It can also be calculated from the numbers for the whole company:
Ipca Laboratories Business Description
Traded in Other Exchanges
Address
125, Kandivli Industrial Estate, Kandivli (West), Mumbai, MH, IND, 400067
Ipca Laboratories Ltd is a pharmaceutical company. The company's principal activity is the Development, Manufacturing, and Marketing of Pharmaceuticals Products. The company's API products include Atenolol (anti-hypertensive), Chloroquine Phosphate (anti-malarial), Chlorthalidone (diuretic), Furosemide (diuretic), Hydroxychloroquine Sulphate (DMARD), Losartan. The company has only one reportable primary business segment, pharmaceuticals.
Ipca Laboratories Headlines
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
BOM:524494 has been successfully added to your